Source: Annual Congress 2013 –COPD: acute exacerbations and others
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lainscak, L. Tavazzi, K. Swedberg, M. Komajda, M. Böhm, J. Borer, M. Robertson, I. Ford (Golnik, Slovenia; Cotignola, Italy; Göteborg, Sweden; Paris, France; Homburg/Saar, Germany; Brooklyn and New York, United States Of America; Glasgow, United Kingdom). LATE-BREAKING ABSTRACT: Clinical profile, outcomes, and ivabradine effects in patients with chronic obstructive pulmonary disease and chronic heart failure: the SHIFT trial analysis. Eur Respir J 2013; 42: Suppl. 57, 1860

Member's Comments

No comment yet.

Related content which might interest you: Carvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease: A nationwide population-based study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 LATE-BREAKING ABSTRACT: Heart failure with preserved ejection fraction in patients with chronic obstructive pulmonary disease exacerbation is associated with poor long-term survival Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases Year: 2013 LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF) Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction Source: International Congress 2014 – Comorbidities Year: 2014 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment Year: 2013 The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Short-term outcomes in community heart failure patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Comorbidities and management in primary care Year: 2011 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Mild cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic review and meta-analysis Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Tiotropium in chronic obstructive pulmonary disease: Gender differences in outcomes Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 LATE-BREAKING ABSTRACT: Evaluation of symptoms and risk on stable chronic obstructive pulmonary disease patients with radiographic bronchiectasis Source: International Congress 2014 – Predictors Year: 2014 Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 LATE-BREAKING ABSTRACT: Multidimensional assessment of patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Predictors Year: 2014 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016